You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Opportunity Cost of Funding Drugs for Rare Diseases
|
|---|---|
| Published in |
Medical Decision Making, July 2014
|
| DOI | 10.1177/0272989x14539731 |
| Pubmed ID | |
| Authors |
Doug Coyle, Matthew C. Cheung, Gerald A. Evans |
| Abstract |
. Both ethical and economics concerns have been raised with respect to the funding of drugs for rare diseases. This article reports both the cost-effectiveness of eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and its associated opportunity costs. |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 25% |
| Spain | 1 | 13% |
| Morocco | 1 | 13% |
| India | 1 | 13% |
| Ireland | 1 | 13% |
| Unknown | 2 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 88% |
| Practitioners (doctors, other healthcare professionals) | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 105 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 15% |
| Student > Bachelor | 16 | 15% |
| Student > Master | 14 | 13% |
| Other | 11 | 10% |
| Student > Ph. D. Student | 10 | 9% |
| Other | 21 | 19% |
| Unknown | 20 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 33 | 31% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 13% |
| Economics, Econometrics and Finance | 9 | 8% |
| Nursing and Health Professions | 6 | 6% |
| Social Sciences | 5 | 5% |
| Other | 17 | 16% |
| Unknown | 24 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 September 2022.
All research outputs
#1,663,582
of 26,017,215 outputs
Outputs from Medical Decision Making
#107
of 1,493 outputs
Outputs of similar age
#16,107
of 246,070 outputs
Outputs of similar age from Medical Decision Making
#2
of 8 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,493 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.0. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 246,070 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.